Chapter

Cardiovascular disease

Christopher W. McIntyre

in Landmark Papers in Nephrology

Published on behalf of Oxford University Press

Published in print March 2013 | ISBN: 9780199699254
Published online April 2013 | e-ISBN: 9780191763519 | DOI: http://dx.doi.org/10.1093/med/9780199699254.003.0016

Series: Landmark Papers in

Cardiovascular disease

Show Summary Details

Preview

Chapter 16 focuses on key milestones in expanding our understanding of the individual components of the pathophysiological processes and how they interact. Cardiovascular disease remains the major killer of people with kidney disease, and up to know attempts to ameliorate this (especially in patients receiving dialysis) using therapies developed for treatment in the non uraemic general population have almost universally been ineffective. New targets should result in novel interventions and we are only just entering the era of robust testing of this expanded envelope of therapeutic possibilities.

Chapter.  7585 words. 

Subjects: Nephrology ; Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.